Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 8 trials

Late-Stage Pipeline

38%

3 trials in Phase 3/4

Results Transparency

0 of 0 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

N/A

3(37.5%)

Phase 4

2(25.0%)

Phase 2

1(12.5%)

Phase 3

1(12.5%)

Phase 1

1(12.5%)

8Total

N/A(3)

Phase 4(2)

Phase 2(1)

Phase 3(1)

+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials

NCT07438119Phase 4Not Yet Recruiting

Efficacy Comparison of DExamethasone Intravitreal Implant Combined With Aflibercept Versus Aflibercept Monotherapy in Treatment-naïve Inflammatory Diabetic Macular Edema Patients

Role: collaborator

NCT06770296Phase 1Recruiting

The Dosing Regimen of Pyrotinib in HER2-positive Advanced First-line Breast Cancer: a Phase I Clinical Study

Role: collaborator

NCT05756959Not ApplicableRecruiting

Myopia Control Combined PBM With Myopic Defocus Lens in Children

Role: collaborator

NCT05628909Not ApplicableUnknown

Silicone Oil Tamponade for Vitrectomy of Hypermyopic Foveoschisis.

Role: collaborator

NCT05439707Not ApplicableUnknown

Effects of Perioperative Transauricular Vagus Nerve Electrical Stimulation on POD, POCD and CPSP

Role: collaborator

NCT02447185Phase 3Unknown

25-G Vitrectomy With Ranibizumab or Triamcinolone Acetonide on PDR in China-Randomized Clinical Trial

Role: collaborator

NCT03425708Phase 4Unknown

Effect of Hyperuricaemia on Chronic Renal Disease

Role: collaborator

NCT02328118Phase 2Unknown

25-Gauge Vitrectomy With Ranibizumab or Triamcinolone Acetonide on Proliferative Diabetic Retinopathy in China

Role: collaborator

All 8 trials loaded